logo
Select company
Select metric
$ 163.23MNet Cash Flow - Investing
VS
Market
95
Sector
96
Industry
96
History
80
$ 1.42Close
$ 0.29 - $ 2.08 52-Week Range
Ticker Information

Ticker

LXRX

Company Name

LEXICON PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXICON PHARMACEUTICALS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LXRX - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ 163.23M
3/31/2025$ 135.43M
12/31/2024$ -15.38M
9/30/2024$ -17.18M
6/30/2024$ -109.97M
3/31/2024$ -172.26M
12/31/2023$ -49.94M
9/30/2023$ -77.67M
6/30/2023$ -115.54M
3/31/2023$ -54.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXICON PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Investing stands at $ 227.26M.
  • Over the past 5 years, LEXICON PHARMACEUTICALS INC's average CF - Investing has been $ 37.79M.
  • The median CF - Investing for LEXICON PHARMACEUTICALS INC during this period was $ -13.87M
  • LEXICON PHARMACEUTICALS INC reached its highest CF - Investing over the past 5 years at $ 380.76M.
  • The lowest CF - Investing recorded by LEXICON PHARMACEUTICALS INC in the same timeframe $ -172.26M

LEXICON PHARMACEUTICALS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
NKTR : NEKTAR THERAPEUTICS $ 199.63MXOMA : XOMA ROYALTY CORP $ -53.58MCDXS : CODEXIS INC $ 10.07MGOSS : GOSSAMER BIO INC $ 92.65MSCPH : SCPHARMACEUTICALS INC $ -21KSAGE : SAGE THERAPEUTICS INC $ 254.43MADCT : ADC THERAPEUTICS SA $ -570KYMAB : Y-MABS THERAPEUTICS INC $ -127KETON : ETON PHARMACEUTICALS INC $ -38.13MZVRA : ZEVRA THERAPEUTICS INC $ -14.35M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

LXRX - Net Cash Flow - Investing, Last 5 years

$ -172.26M

Minimum

Mar 31, 2024

$ 380.76M

Maximum

Dec 31, 2020

$ 37.79M

Average

$ -13.87M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M